Tagged with Sanfer

LatAm Pharma Roundup: Sanfer Acquires Columbian Injectables Maker Vitalis; Chile Moves Towards Universal Care

LatAm LatAm Pharma Roundup: Sanfer Acquires Columbian Injectables Maker Vitalis; Chile Moves Towards Universal Care

LatAm A roundup of some of the latest stories from Latin American pharma and healthcare, including Sanfer’s acquisition of Columbia-based injectables manufacturer Vitalis; medicine shortages in Colombia, and Chile’s move towards universal primary health coverage with support from the World Bank. ACON Investments Signs Definitive Agreement to Sell Vitalis to…

Long Read: The Future of Healthcare in Latin America

LatAm Long Read: The Future of Healthcare in Latin America

LatAm A vibrant and diverse continent, home to over 650 million people and the highest life expectancy among developing regions, Latin America is now emerging as a globally relevant life sciences investment destination. LatAm has a robust heritage of scientific achievement – Bernardo Houssay (1947) and César Milstein (1984) of Argentina…

Mexico: Sanfer Looking to Build on LatAm Footprint with Europe, Asia & US Expansions

Mexico Mexico: Sanfer Looking to Build on LatAm Footprint with Europe, Asia & US Expansions

Mexico Mexico, with the second largest pharmaceutical market in Latin America, has a number of strong local pharma industry players. These companies, no longer focused solely on the domestic market, are extending their footprint into LatAm. Grupo Sanfer/Hormona Mexico has already taken up positions across the region. Laboratorios Sanfer, founded…

Dagoberto Cortés Cervantes – Director, Grupo Sanfer/Hormona Mexico

Mexico Dagoberto Cortés Cervantes – Director, Grupo Sanfer/Hormona Mexico

Mexico Dagoberto Cortés Cervantes, president of Mexico’s National Association of Medicines Manufacturers (ANAFAM) and director of Grupo Sanfer/Hormona Mexico, outlines the expansion strategy that has led the manufacturing group to extend its presence beyond Mexico into the broader LatAm region and the importance of the “Alianza del Pacifico” trade agreement linking…

Top 10 Pharma Companies in Mexico

Mexico Top 10 Pharma Companies in Mexico

Mexico A compilation of the top 10 pharmaceutical companies in the Mexican pharmaceutical market based on IQVIA data from February MAT 2020. Four of the top ten companies are Mexican: PISA, Sanfer, Senosiain and Siegfried Rhein. 1. Sanofi Global CEO: Paul Hudson Country Chair: Fernando Sampaio Sanofi has had a…

Interview: Ricardo Amtmann – President, Laboratorios Sanfer, Mexico

Mexico Interview: Ricardo Amtmann – President, Laboratorios Sanfer, Mexico

Mexico Ricardo Amtmann, President at Laboratorios Sanfer, explains how they have grown their business by 100 percent throughout the last three years and showcases the added value of Sanfer to patients in Mexico and internationally by offering high quality drugs and boosting the sales of in-licensed medicines. Could you introduce yourself…

Other Topics

India

M&A

European Biotech

Cell & Gene Therapy

R&D Section Page